88 results about "Jaundice" patented technology

The invention relates to the technical field of pediatric medical treatment, and discloses a pediatric neonatal jaundice clinical phototherapy management system, which integrates illumination data in an equipment lamp box through a data integration module, extracts the illumination data acquired by the data integration module through a fusion analysis module, and fuses the operation duration of a lamp tube to obtain a phototherapy result. An equipment health state basic model is established, the current equipment health state is predicted through an equipment prediction module on the basis of the established health state basic model, a prediction result is fed back, a patient information system is connected through a personality support module, and basic physiotherapy data of a patient is acquired. And outputting recommended illumination intensity and recommended treatment time based on the basic physiotherapy data, and monitoring a plurality of pieces of monitoring information and feedback output results through a remote monitoring module. The system accurately solves the core problems of dynamic fluctuation of phototherapy intensity, calibration lag and lack of personalized adaptation, and finally achieves dual guarantee of phototherapy effect and safety.

The invention relates to the technical field of medical instruments, in particular to an intelligent temperature control phototherapy swaddle which comprises a swaddle body. The transparent elastic air bag is arranged on the inner wall of the swaddle body; the first sensor is arranged on the transparent elastic air bag; the blue light emitting assembly is arranged on the inner wall of the swaddle body; the electric control box is connected with the swaddling clothes body and comprises a box body; the conveying pump assembly, the heating assembly, the control assembly and the power supply assembly are arranged in the box body; the conveying pump assembly is connected with the transparent elastic air bag and the heating assembly, the conveying pump assembly is used for conveying a medium heated in the heating assembly into the transparent elastic air bag, and through back-and-forth contraction of the transparent elastic air bag, a newborn can be massaged while the medium heated in the heating assembly is heated by the transparent elastic air bag. External dry air can be sucked into the swaddling clothes body, so that the sweating frequency of the newborn baby is reduced, the body is kept dry and comfortable, and the comfort degree is improved.

The utility model discloses a jaundice irradiation device for pediatric treatment, and particularly relates to the technical field of child medical treatment, the jaundice irradiation device comprises supporting legs, the upper ends of the supporting legs are fixedly connected with a protective shell, the protective shell is fixedly connected with a rocking bed, and the right part of an inner cavity of the protective shell is fixedly connected with a transmission assembly; the bottom wall of the inner cavity of the protective shell is fixedly connected with a treatment assembly, and the right end of the transmission assembly is fixedly connected with a matching assembly. According to the jaundice irradiation device for pediatric treatment, the device treatment assembly is arranged to be matched with the device transmission assembly, so that a child can swing back and forth when being put into an inner cavity of a transparent soft cushion of the device, the child can be pacified, treatment can be completed when the child falls asleep, and the treatment effect is good. Furthermore, a device gear II is meshed with a device rotating ring, so that light of the device on a connecting plate can rotate by 360 degrees around the child, and the child is treated.

The invention belongs to the technical field of biological medicines, and particularly relates to application of ganoderic acid A in preparation of a medicine for preventing and / or treating biliary atresia. The new application of ganoderic acid A in preparation of drugs for preventing and / or treating biliary atresia is found for the first time. The method comprises the following steps: within 24 hours after a BALB / c newborn mouse is born, inducing the formation of BA by intraperitoneal injection of RRV, and from the second day after intraperitoneal injection of RRV, carrying out intraperitoneal injection of Ganoderic Acid A on the mouse every day until the twelfth day, it can be observed that the survival time of BA mice treated by the Ganoderma Acid A is prolonged, the weight loss is obviously improved, the jaundice symptom is relieved, the liver function index is obviously improved, the infiltration number of inflammatory cells around the intrahepatic bile duct is obviously reduced, and the liver bile duct injury is relieved. The invention provides a new potential target and a treatment strategy for treatment of BA, and has potential clinical treatment significance.

The invention discloses an application of a pyroptosis inhibitor in preparation of a product for treating biliary atresia, the pyroptosis inhibitor 2-bromohexadecanoic acid has a certain treatment effect on biliary atresia mice, can significantly prolong the survival time of the mice, improve jaundice, improve the liver function of the mice, reduce the infiltration quantity of inflammatory cells around intrahepatic bile ducts, and can be used for treating the biliary atresia. A new potential target and a treatment strategy are provided for treatment of biliary atresia.

The invention relates to a chemiluminescence kit for detecting pepsinogen II. The kit comprises an enzyme marker, a luminescent substrate solution and an anti-interference buffer system, the anti-interference buffer system comprises a nonionic surfactant, animal-derived IgG (immunoglobulin G), an antioxidant and catalase; the chemiluminescence kit also comprises a PG II calibration product and a PG II quality control product. The core active component of the enzyme marker is beta-galactosidase. The enzyme marker further comprises an anti-PG II monoclonal antibody marked by beta-galactosidase, bovine serum albumin, trehalose, cane sugar, MgCl2. 6H2O, sodium chloride, Proclin300 and a phosphate buffer solution. According to the kit, a brand-new anti-interference buffer system is introduced on the basis of a spatial proximity chemiluminescence analysis method, so that the resistance to clinically common interferents (such as hemolysis, lipemia, jaundice and heterotropism antibodies) is remarkably improved, and the detection result is more accurate and reliable.

The invention relates to the technical field of albumin oligopeptides, in particular to a preparation method of albumin oligopeptides and application of the albumin oligopeptides in promotion of postoperative patient recovery. The albumin oligopeptide provided by the invention can be taken before, during or after an operation, not only can quickly promote postoperative recovery and reduce the content of total bilirubin and direct bilirubin of a patient, but also can reduce the activity of glutamic oxalacetic transaminase and glutamic-pyruvic transaminase, and also can reduce the activity of carbohydrate antigen 199 and the content of alpha fetoprotein. In addition, by taking the albumin oligopeptide, the bitter throat dryness can be improved, nausea and vomiting symptoms can be eliminated, and the albumin oligopeptide has the effect of promoting postoperative liver function recovery of obstructive jaundice.

The invention relates to the field of traditional Chinese medicine preparations, in particular to a traditional Chinese medicine composition for treating non-alcoholic fatty liver, a preparation method of the traditional Chinese medicine composition and application of the traditional Chinese medicine composition to treatment of the non-alcoholic fatty liver. The traditional Chinese medicine composition is composed of artemisia capillaries, rhizoma anemones raddeanae, fructus gardeniae and rheum officinale. Artemisia capillaris is used as a monarch drug and has the effects of clearing heat, promoting diuresis, benefiting gallbladder and removing jaundice; the two head hairs and the fructus gardeniae are used as ministerial drugs, the former drugs clear away heat and toxic materials, relieve pain and regulate liver lipid metabolism, and the latter drugs purge fire, relieve restlessness, clear heat and promote diuresis; rheum officinale is used as an assistant and guide drug and has the effects of purging heat, removing stasis and relaxing bowels. All the components have a synergistic effect and jointly exert the effect of treating NAFLD.

The application discloses a sample information identification method, a computer readable storage medium and an identification device. The sample information identification method comprises the following steps: transporting a sample tube to a first identification area by controlling a transportation guide rail, acquiring sample tube information by a sample tube information reading mechanism; controlling an identification mechanism to capture a first image information of the sample tube; analyzing the first image information to acquire first identification information; comparing the first identification information with the sample tube information; if the first identification information matches the sample tube information, adjusting the position of a mechanical hand according to the first identification information to clamp the sample tube and move the sample tube to a second identification area; and acquiring sample information of the sample tube located in the second identification area. According to the sample information, whether the blood sample in the sample tube has hemolysis, jaundice and chyle phenomena and the severity information of the disease can be obtained, so that an abnormal sample with a relatively large influence on detection error can be identified.

The invention discloses an intelligent medical system based on a portable shared jaundice instrument and a use method, and the system comprises a patient end which is used for equipment leasing, payment and measurement display; the portable jaundice instrument terminal is used for acquiring data and wirelessly transmitting the data; the cloud service platform analyzes the data based on an AI algorithm and generates diagnosis suggestions; the medical care terminal is used for auditing the data and pushing a result; the rental cabinet terminal manages access of equipment; and the data collaboration module is used for realizing data synchronization between each terminal and the hospital server. According to the invention, through deep integration of a shared leasing mode and AI cloud auxiliary diagnosis, three breakthroughs of jaundice detection are realized: professional detection is extended to families through Internet of Things hardware and a cloud auxiliary system; a cloud dynamic calibration algorithm effectively assists household measurement operation and eliminates regional skin color interference, and the deviation between the system and manual measurement is reduced; a'user-cloud-doctor 'three-level closed-loop system is constructed, the overall screening efficiency is improved, and jaundice full-link management and hierarchical diagnosis and treatment are supported.

The invention belongs to the technical field of pediatric medicine, and particularly relates to a jaundice irradiation device for pediatric nursing and a use method. Comprising a base, a bearing shell is fixedly connected to the base, a shielding shell is fixedly connected to the bearing shell, a covering shell is hinged to the shielding shell, an irradiation lamp is installed on the covering shell, a supporting shaft is arranged on the bearing shell, a supporting frame is fixedly connected to the middle of the supporting shaft, and first push rods which are symmetrically distributed are hinged to the supporting frame; a mounting plate is hinged to the telescopic end of the first push rod, chain plates distributed in an array mode are hinged to the mounting plate, and a sliding rod is arranged on the side, away from the corresponding mounting plate, of each chain plate. The baby is pushed through bending of all the chain plates on the same side, so that the baby rotates slowly, the turning operation of the baby is assisted, the operation difficulty of a doctor is reduced, the turning operation is smoother, and the crying probability of the baby is reduced.

This item is notebook paper used for recording neonatal jaundice and physiological weight loss.

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating hepatobiliary diseases, the traditional Chinese medicine composition has the effects of soothing liver-gallbladder, clearing away heat and toxic materials, promoting qi circulation, dispersing blood stasis, regulating qi, activating blood, benefiting gallbladder and removing urinary calculus, and is clinically used for treating cholelithiasis, cholecystitis, jaundice, hepatitis and other diseases. The preparation has the advantages of good curative effect, small side effect, low price, convenience in taking and the like, and exerts the unique advantage of the traditional Chinese medicine in treating hepatobiliary diseases.

The application relates to the field of biological medicine, and discloses application of folic acid in prevention, diagnosis and treatment of genetic, infectious or allergic diseases. The application finds that the folic acid can achieve the prevention and treatment effects on the genetic, infectious or allergic diseases by improving inflammation, regulating iron ion metabolism, correcting intestinal flora disorder, reducing liver / intestinal tissue damage, inhibiting expression of inflammatory factors and promoting expression of Nox2. Meanwhile, the application provides application of one or more of the folic acid, S100a8, S100a9, Nox2 and IFN-gamma as a diagnostic or auxiliary diagnostic marker of biliary atresia. Meanwhile, the application provides the folic acid or a derivative thereof, which is prepared into food, a nutritional preparation or a medicine and applied to children or adults, so as to achieve the purposes of preventing and treating biliary atresia, cholangitis, jaundice, infectious diseases, intestinal diseases and diseases caused by abnormal folic acid metabolism.

The utility model discloses a jaundice treatment device, and relates to the technical field of medical equipment. The device comprises a top plate, connecting shafts are symmetrically and rotatably connected to the two sides of the top plate through bearings, side plates are fixedly connected to the two connecting shafts in a sleeved mode, shading cloth is fixed to the middles of the side plates, a driving box is fixedly connected to the rear side of the top plate, and the rear ends of the two connecting shafts extend into the driving box and are fixedly connected with worm wheels in a sleeved mode. And a double-end worm is rotationally connected in the driving box above the worm gear through a bearing. By rotating the double-end worm, the two connecting shafts can be driven to rotate in opposite directions, then the side plates can be driven to be unfolded or folded, storage and carrying are convenient, after the side plates are unfolded, an infant can be directly covered with the side plates, jaundice treatment is carried out on the infant, the use occasion is more flexible, personnel can conveniently check the situation of the infant at any time, and the practicability is high. The side plates and the shading cloth are connected in a hook-and-loop fastener pasting mode, and people can conveniently detach and clean the shading cloth.

The application belongs to the technical field of biological detection, and particularly relates to the use of apolipoprotein A-I in the preparation of a diagnostic reagent or system for predicting the risk of severe acute hepatitis E. The application first discloses and verifies the significant correlation between the serum apolipoprotein A-I (apoA-I) level and the adverse clinical outcomes (including severe jaundice, liver failure and death) of patients with acute hepatitis E, and establishes the risk interpretation threshold (0.675 g / L and 0.435 g / L) with clinical practical value. The application can objectively and early identify high-risk patients, and provides a powerful auxiliary tool for clinical stratified management and resource optimization.

The invention relates to the technical field of medical instruments, in particular to a control method and system of a jaundice treatment device. The method comprises the following steps: acquiring evaluation data of a user, wherein the evaluation data comprises spectral reflectivity; inputting the evaluation data into a preset prediction model to obtain a bilirubin concentration risk score and a bilirubin concentration prediction value at a next prediction moment; in response to the bilirubin concentration risk score being greater than a risk threshold, determining a candidate interval corresponding to a phototherapy parameter based on the bilirubin concentration risk score, the phototherapy parameter including a light source wavelength; inputting the predicted value of the bilirubin concentration into an MPC optimizer, so that the MPC optimizer selects an optimal phototherapy parameter from the candidate interval; and outputting the optimal phototherapy parameter, so that the jaundice treatment device outputs a corresponding treatment light source. According to the method, the condition of excessive treatment can be avoided.

Disclosed in the present application are a jaundice risk index evaluation method and apparatus, a computer device and a storage medium. The method comprises: determining a skin area to be measured; successively measuring said skin area by means of a measurement instrument, so as to obtain a plurality of successive pieces of real transcutaneous bilirubin (TcB) information of said skin area; according to the plurality of successive pieces of real transcutaneous bilirubin (TcB) information of said skin area, determining successive transcutaneous bilirubin absolute value change information TcB(t); and, on the basis of the successive transcutaneous bilirubin absolute value change information TcB(t), determining a jaundice risk index by means of a risk index prediction model. By determining the plurality of successive pieces of real transcutaneous bilirubin (TcB) information of the skin area to be measured by means of successive measurements, then determining the successive transcutaneous bilirubin absolute value change information TcB(t) on this basis, and estimating the progression of jaundice on the basis of the successive transcutaneous bilirubin absolute value change information TcB(t), the present application can measure the concentration of subcutaneous bilirubin accurately, and provides a prediction function for the progression trend of jaundice.

The invention relates to the technical field of probiotics, and discloses a probiotic preparation for improving abnormal bile diseases of newborns. According to the probiotic preparation provided by the invention, lactobacillus fermentum CECT5716, bifidobacterium breve M-16V and bifidobacterium longum subsp. Longum BB536 in the list of strains for infants are selected as a product formula, and the probiotic preparation can be used for effectively improving abnormal bile diseases of newborns, including jaundice, hyperbilirubinemia and cholestasis, and can be used for preventing and treating the abnormal bile diseases of the newborns, such as jaundice, hyperbilirubinemia and cholestasis. The problems that in the prior art, safety is insufficient, pertinence is insufficient, and clinical requirements of complex illness conditions cannot be met are effectively solved.

The invention relates to an external preparation for treating skin itch of a patient with jaundice and a preparation method of the external preparation, and relates to the technical field of traditional Chinese medicine. The traditional Chinese medicine extract comprises the following raw materials in parts by weight: 25-35 parts of humulus lupulus, 10-20 parts of chionanthus retusus leaves and 10-20 parts of rhizoma tupistrae chinensis. A proper amount of humulus lupulus, chionanthus retusus leaves and rhizoma tupistrae chinensis are matched and used as functional components, and the humulus lupulus, the chionanthus retusus leaves and the rhizoma tupistrae Meanwhile, by combining a gradient decompression reflux extraction mode, effective components are efficiently extracted and fully reserved, so that the improvement effect of the obtained traditional Chinese medicine composition on the skin itch symptom of the jaundice patient is remarkably improved, the treatment effect is superior to that of an existing conventional medicine, a new means is provided for treating the skin itch disease of the jaundice patient, and the application prospect is wide.

The utility model belongs to the technical field of jaundice therapeutic instruments, and particularly relates to an adjusting mechanism of a neonatal jaundice therapeutic instrument, a lower shell and an end cover are arranged in a hinged mode, four sets of first telescopic rods are arranged in the shell, the extending ends of the four sets of first telescopic rods are provided with a bearing plate, the bearing plate is provided with a sliding block in a sliding mode, and the sliding block is connected with the lower shell. The sliding block is provided with an auxiliary support, the sliding block is driven by a power device, a lifting mechanism is arranged between the sliding block and the auxiliary support, the auxiliary support is provided with a plurality of groups of blue light irradiation lamps at intervals, the bearing plate is provided with a bearing groove, the lower shell and the upper end cover are provided with hole bodies, and the upper end cover and the lower shell are connected through the hole bodies. And a head placing plate matched with the hole body is arranged on the lower shell.

The invention discloses application of an NLRP3 inhibitor in preparation of a medicine for treating biliary atresia. The NLRP3 inhibitor can selectively inhibit inflammasome NLRP3 generated due to activation of an abnormal universal apoptosis pathway, further inhibits a proinflammatory factor product IL-1beta, effectively relieves formation of biliary duct atresia of BA mice, reduces the jaundice rate, and improves the body weight and the survival rate.

A jaundice diagnosis and treatment system includes a control circuit, a bilirubin measurement assembly, a risk evaluation circuit and a display assembly, wherein the bilirubin measurement assembly is communicatively connected to the control circuit, and is used for measuring a bilirubin concentration of a newborn baby and transmitting the measured bilirubin concentration to the control circuit, so that the control circuit generates measurement data according to the measured bilirubin concentration; the risk evaluation circuit is communicatively connected to the control circuit, and is used for acquiring the measurement data from the control circuit and evaluating a pathologic jaundice risk level according to the measurement data; and the display assembly is connected to the control circuit, and is used for displaying the measurement data and / or the pathologic jaundice risk level under the control of the control circuit.

The invention discloses a pediatric nursing jaundice irradiation device, and relates to the technical field of jaundice irradiation, the pediatric nursing jaundice irradiation device comprises a box body, the box body is rotatably connected with a rotating shaft, and the rotating shaft is fixedly sleeved with a U-shaped frame. Through the arrangement of the automatic material changing mechanism, a first motor drives a driving wheel to rotate, the driving wheel rotates to drive a rotating wheel and a driving roller to rotate, and the driving roller rotates to drive a conveying belt to rotate; when the hook-and-loop fastener thorn faces move to the position of the connecting roller, the hook-and-loop fastener thorn faces can be bonded with the hook-and-loop fastener loop faces of the bed sheet to be replaced, the bed sheet is fed, automatic replacement of the bed sheet of the newborn baby is achieved, the work efficiency is improved, and the work efficiency is improved. Therefore, the bed sheet can be replaced more conveniently and quickly, and neonatal jaundice is not affected.

The application discloses a traditional Chinese medicine granule for treating jaundice and a preparation method and application thereof. The traditional Chinese medicine granule is prepared from the following traditional Chinese medicine raw materials in parts by mass: radix rehmanniae 14-16 parts, radix et rhizoma rhei 6.5-8.5 parts, fructus aurantii immaturus 6.5-8.5 parts, radix pini 6.5-8.5 parts, herba taraxaci 14-16 parts. The traditional Chinese medicine granule is used for treating jaundice, acute and chronic hepatitis mainly manifested as jaundice (yellowish urine), and the clinical manifestations are yellowish urine, abdominal distension or abdominal distension and pain, poor appetite, yellow urine, dysuria, constipation or diarrhea, red or dark red tongue, yellow tongue fur, and slow and thin pulse. The traditional Chinese medicine granule is determined through years of clinical application, and the results show that the traditional Chinese medicine granule can be used for treating jaundice caused by various acute and chronic hepatitis, and the curative effect is very good, the effect is fast, the curative effect is accurate, the medicine is less, and the cost is low.

The utility model relates to the technical field of medical instruments, and discloses a jaundice irradiation therapy instrument for the pediatric department. The jaundice irradiation therapy instrument for the pediatric department comprises an air inlet pipe, an electric heating plate is fixedly installed in the air inlet pipe, a connecting pipe is installed at the rear end of the air inlet pipe in a penetrating mode, a supporting frame is fixedly installed at the rear end of the air inlet pipe, a PLC is fixedly installed in the supporting frame, and an air pump is fixedly installed in the center of the supporting frame; a hose is fixedly installed at the rear end of the air pump, a supporting plate is fixedly installed above the air inlet pipe, electric heating plates are installed in the air inlet pipe at equal intervals left and right, the electric heating plates can heat air in the air inlet pipe, the air pump communicates with the air inlet pipe through a connecting pipe, and hot air in the air inlet pipe is conveyed into the hose through the air pump; and the upper end of the hose is inserted into the rear side of the end cover, so that hot air can be conveniently guided into the sliding cover, and the situation that a child patient is scalded due to direct contact with the heating structure can be avoided in the mode.

This invention belongs to the field of traditional Chinese medicine oral decoction preparation technology. Specifically, it relates to a method for preparing a stable and safe decoction of traditional Chinese medicine composition for hepatitis, jaundice virus, cirrhosis, and ascites. The decoction is prepared by decocting the following eleven traditional Chinese medicine components: 30g of raw Lysimachia christinae, 30g of Plantago asiatica, 30g of Poria cocos peel, 30g of Dioscorea opposita, 26g of Areca catechu peel, 16g of Salvia miltiorrhiza, 16g of Bupleurum chinense, 16g of Alisma plantago-aquatica, 16g of Astragalus membranaceus, 13g of Lycopus lucidus, and 10g of processed pangolin scales. When decocting, pour the mixture into a sterilized and cleaned porcelain medicine pot, add cold water and soak for 30 minutes. Bring to a boil over high heat, then simmer over low heat for 20 minutes. Turn off the heat and let it cool slightly before drinking. This is the medicine product. By combining classical traditional methods with modern decoction technology, the decoction of these eleven traditional Chinese medicines yields a traditional Chinese medicine preparation with significant effects and convenient administration. This formula features comprehensive regulation and enhancement. It selects herbs such as Lysimachia christinae, Plantago asiatica, Poria cocos, and Salvia miltiorrhiza, which have antibacterial, drainage, dampness-removing, anti-inflammatory, and blood-stasis-removing components for liver ascites. The combination of eleven Chinese herbs has anti-inflammatory, detoxifying, and dampness-removing effects, which are beneficial for treating liver ascites lesions, removing hepatitis, jaundice, tuberculosis, damp-heat accumulation, inflammation-induced ascites, enhancing immunity, and healing effects.

1. The name of this design product: Transcutaneous Jaundice Device. 2. Purpose of this design product: used for jaundice detection in infants and young children. 3. The key point of the design of this product lies in its shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

The invention relates to the field of intelligent medical treatment, in particular to a variation parameter calculation method and device for biochemical indexes of lipemia, hemolysis and jaundice and a program product. Comprising the following steps: acquiring a lipid serum sample set and a normal serum sample set; performing biochemical index detection on the lipid serum sample set and the normal serum sample set to obtain a first biochemical value and a second biochemical value; mixing the lipid serum sample set with the normal serum sample set to obtain a mixed serum sample set, and performing biochemical index detection on the mixed serum sample set to obtain a third biochemical value; performing mean value calculation on the first biochemical value and the second biochemical value to obtain a biochemical theoretical mean value; and performing variation coefficient calculation on the biochemical theoretical mean value and the third biochemical value to obtain a variation parameter. The method can be used for calculating corrected biochemical indexes of lipemia, hemolysis and jaundice, and has good clinical value.

The present invention relates to providing protective immunity to canine animals against leptospira jaundice hemorrhagic serotypes with vaccines comprising non-jaundice hemorrhagic leptospira serotypes.